These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6068006)

  • 1. The preparation and properties of a stable factor V from bovine plasma.
    Barton PG; Hanahan DJ
    Biochim Biophys Acta; 1967 Apr; 133(3):506-18. PubMed ID: 6068006
    [No Abstract]   [Full Text] [Related]  

  • 2. Some lipid-protein interactions involved in prothrombin activation.
    Barton PG; Hanahan DJ
    Biochim Biophys Acta; 1969 Oct; 187(3):319-27. PubMed ID: 5367454
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the stability of bovine plasma factor V.
    Day WC; Barton PG
    Biochim Biophys Acta; 1971 Feb; 261(2):457-68. PubMed ID: 5169152
    [No Abstract]   [Full Text] [Related]  

  • 4. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabbit factor V: different effects of thrombin and venom, a source of error in assay.
    Rapaport SI; Hjort PF; Patch MJ
    Am J Physiol; 1966 Dec; 211(6):1477-85. PubMed ID: 5956566
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation and activity of factor V from small quantities of bovine plasma.
    White NB; Ferguson JH; Hitsumoto S
    Am J Med Sci; 1968 Feb; 255():143-51. PubMed ID: 5689081
    [No Abstract]   [Full Text] [Related]  

  • 8. OUTSTANDING CHARACTERISTICS OF THROMBOKINASE ISOLATED FROM BOVINE PLASMA.
    MILSTONE JH; OULIANOFF N; MILSTONE VK
    J Gen Physiol; 1963 Nov; 47(2):315-27. PubMed ID: 14080818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accelerin (factor V), the catobolic product of fibrinogen ].
    Chulkova T; Victoreo L
    Biull Eksp Biol Med; 1976 Aug; 82(8):950-2. PubMed ID: 1026295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombus formation on polymeric materials. IV. Behavior of blood proteins at interfaces.
    Olsen DA; Kletschka HD; Haynes JL
    Minn Med; 1971 Aug; 54(8):635-41. PubMed ID: 4934851
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetic properties and molecular size of thrombin-activated favtor V.
    Colman RW; Moran J; Philip G
    J Biol Chem; 1970 Nov; 245(22):5941-6. PubMed ID: 5530157
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
    Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PURIFICATION AND PROPERTIES OF BOVINE FACTOR V: A CHANGE OF MOLECULAR SIZE DURING BLOOD COAGULATION.
    PAPAHADJOPOULOS D; HOUGIE C; HANAHAN DJ
    Biochemistry; 1964 Feb; 3():264-70. PubMed ID: 14163951
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of chymotrypsinogen by preparations of thrombokinase derived from bovine plasma.
    Milstone JH; Milstone VK
    Thromb Diath Haemorrh; 1967 May; 17(3-4):388-400. PubMed ID: 5626769
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation factor V exists uncomplexed in bovine plasma.
    Ittyerah TR; Rawala R; Colman RW
    Biochim Biophys Acta; 1982 Feb; 714(3):524-9. PubMed ID: 6800411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.
    Rapaport SI; Zivelin A; Minow RA; Hunter CS; Donnelly K
    Am J Clin Pathol; 1992 Jan; 97(1):84-91. PubMed ID: 1728869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the formation and activity of factor V-phospholipid complexes. I. Influence of phospholipid structure.
    Kandall CL; Shohet SB; Akinbami TK; Colman RW
    Thromb Diath Haemorrh; 1975 Sep; 34(1):256-70. PubMed ID: 1237944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V.
    Colman RW
    Prog Hemost Thromb; 1976; 3():109-43. PubMed ID: 133374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.